Welltower stock: October 13, 2026 Barclays cut target to USD 246 for Welltower stock
Published on 10/20/2026 at 17:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst target and reporting date
- Barclays cut its Welltower target to USD 246.00 from USD 259.00 on October 13, 2026.
- Second-quarter revenue rose 39.10 percent to USD 3.54 billion.
- Welltower stock costs EUR 211.65 at Lang & Schwarz on October 20, 2026 at 5:02 p.m. CEST, up 1.12 percent versus the Tradegate close.
- Welltower's price-to-earnings ratio was 125.84 at USD 238.02 on the NYSE.
Barclays cut its price target for Welltower Inc. from USD 259.00 to USD 246.00 on October 13, 2026, while keeping an Equal Weight rating, according to Markets Insider. At Lang & Schwarz, Welltower stock was trading at EUR 211.65 on October 20, 2026 at 5:02 p.m. CEST, up 1.12 percent versus the Tradegate close of October 19, 2026 at EUR 209.30.
Target cut puts valuation in view
The Barclays target is 14.00 percent above the current US price of USD 238.02, using the target and the NYSE quotation from October 20, 2026. The target change itself was a 5.02 percent reduction from USD 259.00, making the analyst view more cautious even though the rating stayed at Equal Weight.
Welltower's latest reported operating picture was stronger than the target revision. Revenue reached USD 3.54 billion in the second quarter of 2026, up 39.10 percent from USD 2.55 billion a year earlier, while net income attributable to common stockholders rose 47.40 percent to USD 445.00 million, according to Financial Report Insights.
How does the price compare?
On the NYSE, the stock was last at USD 238.02 on October 20, 2026 at 11:08 a.m. ET. Its 52-week range was USD 173.13 to USD 255.20, placing the quote 6.73 percent below the high and 37.48 percent above the low. The market capitalization was USD 171.5 billion, trading volume was 432,823 shares, and the price-to-earnings ratio was 125.84.
Results date adds a near-term marker
Welltower is scheduled to release third-quarter 2026 results after the NYSE close on October 26, 2026. The company is scheduled to discuss those results on a conference call and webcast on October 27, 2026 at 9:00 a.m. ET, according to Welltower. The upcoming report will put the latest revenue growth and senior-housing operating trends against the revised analyst targets.
Comparison with peers
As of October 20, 2026 at 11:08 a.m. ET, the comparison is: Welltower Inc.: up 1.12 percent, price-to-earnings ratio 125.84, market capitalization USD 171.5 billion. Healthpeak Properties (NYSE, USD): up 1.93 percent, price-to-earnings ratio 53.59, market capitalization USD 12.9 billion. Ventas (NYSE, USD): up 2.25 percent, price-to-earnings ratio 159.93, market capitalization USD 44.3 billion.
Welltower stock stays below its high
The euro quotation is 6.73 percent below the 52-week high in the US quotation, while the latest Barclays target remains above the current NYSE price. The October results date is the next concrete test of whether operating growth can support the valuation.
The further course of trading is shown by the continuously updated real-time quote of Welltower stock.
Welltower stock at a glance
- Company: Welltower Inc.
- ISIN: US95040Q1040
- Ticker: WELL
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 20, 2026, 5:02 p.m. CEST): EUR 211.65
- Change versus Tradegate close: plus 1.12 percent
- Tradegate close (October 19, 2026): EUR 209.30
- Market capitalization: USD 171.5 billion (as of October 20, 2026)
- 52-week range: USD 173.13-255.20 (as of October 20, 2026)
- Sector / Industry: Real Estate / Healthcare Facilities REIT
- Index membership: S&P 500
Market context: Market report S&P 500.
